These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2389421)

  • 1. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses.
    Waaga AM; Ulrichs K; Krzymanski M; Treumer J; Hansmann ML; Rommel T; Müller-Ruchholtz W
    Transplant Proc; 1990 Aug; 22(4):1613-4. PubMed ID: 2389421
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of specific tolerance by 15-deoxyspergualin (DOS) treatment after rat skin and kidney transplantation in rats. Analysis of effectivity of various protocols of DOS application.
    Waaga AM; Krzymański M; Ulrichs K; Oko A; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):143-53. PubMed ID: 8915520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin.
    Schorlemmer HU; Dickneite G; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1626-30. PubMed ID: 2389427
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of 15-deoxyspergualin on MHC class I and II antigen expression following small bowel transplantation in rats.
    Fändrich F; Waaga AM; Jacob S; Schröder J; Schweizer E; Schroeder P
    Transplant Proc; 1994 Jun; 26(3):1592-3. PubMed ID: 8030051
    [No Abstract]   [Full Text] [Related]  

  • 5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxyspergualin downregulates MHC class II antigen expression and cell migration in models of graft-versus-host and host-versus-graft disease.
    Waaga AM; Fändrich F; Krzymanski M; Eckstein V; Herwartz C; Muller-Ruchholtz W; Russell ME
    Transplant Proc; 1996 Oct; 28(5):2515-7. PubMed ID: 8907930
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of a rat kidney perfusion using the anti-MHC class II monoclonal antibody and reduced dose of 15-deoxyspergualine on the allogeneic graft survival.
    Oko A; Krzymański M; Deja A; Ulrichs K; Waaga AM; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):293-7. PubMed ID: 8744649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and immunohistochemical evaluation of deoxyspergualin-treated rat renal transplants.
    Chikaraishi T; Ishikura H; Kanagawa K; Togashi M; Koyanagi T; Yoshiki T
    Transplant Proc; 1992 Aug; 24(4):1633-4. PubMed ID: 1353923
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow cytometric analysis of graft-infiltrating lymphocytes in deoxyspergualin-treated rat renal transplants.
    Takeuchi I; Chikaraishi T; Kanagawa K; Tanda K; Seki T; Togashi M; Koyanagi T
    Transplant Proc; 1994 Aug; 26(4):1905-6. PubMed ID: 8066620
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
    Ueda H; Itoh S; Kusaka M; Isurugi K
    Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of deoxyspergualin-induced host resistance to graft-versus-host reaction induced with small bowel transplantation in rats.
    Okitsu T; Tanaka S; Orita K
    Transplant Proc; 1995 Apr; 27(2):1609-11. PubMed ID: 7725422
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro analysis of the mode of action of the immuno-suppressive drug 15-deoxyspergualin.
    Waaga AM; Krzymański M; Ulrichs K; Treumer J; Oko A; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):155-63. PubMed ID: 8915521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences.
    Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH
    Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337
    [No Abstract]   [Full Text] [Related]  

  • 16. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of allogeneic transplanted skin grafts by A85 4777, a new immunosuppressive homopiperazine derivative.
    Schorlemmer H; Bartlett RR; Wolf E; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1671-3. PubMed ID: 2389431
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
    Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor pretreatment with deoxyspergualin on prevention of graft-vs-host reaction after small bowel transplantation.
    Kai K; Tanaka S; Orita K
    Transplant Proc; 1996 Jun; 28(3):1847-8. PubMed ID: 8658912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.